Wenli Jiang Selected Research

aspernolide A

10/2021

Soft coral-derived Aspernolide A suppressed non-small cell lung cancer induced osteolytic bone invasion via the c-Fos/NFATC1 signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenli Jiang Research Topics

Disease

5	Neoplasms (Cancer) 03/2022 - 01/2021
3	Bone Resorption 10/2021 - 11/2020
3	Osteolysis 10/2021 - 11/2020
2	Inflammation (Inflammations) 03/2022 - 01/2021
2	Sepsis (Septicemia) 03/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 06/2021 - 11/2020
1	Idiopathic Pulmonary Fibrosis 03/2022
1	Ischemic Stroke 03/2022
1	Type 2 Diabetes Mellitus (MODY) 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2022
1	Colonic Neoplasms (Colon Cancer) 10/2021
1	Lymphoma (Lymphomas) 10/2021
1	Autoimmune Diseases (Autoimmune Disease) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Leukemia 10/2021
1	Carcinoma (Carcinomatosis) 06/2021
1	Acute-Phase Reaction 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Escherichia coli Infections 01/2021
1	Hemorrhage 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Adenocarcinoma 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2018
1	Factor XII Deficiency 01/2016

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2021
2	Actins (F Actin)IBA 10/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 06/2021 - 11/2020
2	CytokinesIBA 06/2021 - 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	AntioxidantsIBA 03/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 03/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	matrigelIBA 01/2022
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	AntibodiesIBA 10/2021
1	aspernolide AIBA 10/2021
1	LipopolysaccharidesIBA 07/2021
1	protocatechualdehydeIBA 07/2021
1	NFATC Transcription FactorsIBA 07/2021
1	RANK LigandIBA 07/2021
1	Suppressor of Cytokine Signaling ProteinsIBA 06/2021
1	InterferonsIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	Viral DNAIBA 01/2021
1	anisodamineIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2020
1	asperolide AIBA 11/2020
1	Tartrate-Resistant Acid PhosphataseIBA 11/2020
1	Hematoxylin (Haematoxylon)IBA 11/2020
1	FITC-annexin A5IBA 11/2020
1	A-factor (Streptomyces)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 11/2018
1	Factor XII (Hageman Factor)IBA 01/2016

Therapy/Procedure

3	Therapeutics 03/2022 - 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Photothermal Therapy 01/2022
1	Phototherapy (Light Therapy) 01/2022
1	Operative Time 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Cholecystectomy 01/2019